Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celestica (CLS) Cash & Equivalents (2016 - 2025)

Celestica (CLS) has disclosed Cash & Equivalents for 10 consecutive years, with $595.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 7439.24% to $595.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $595.6 million through Dec 2025, up 7439.24% year-over-year, with the annual reading at $595.6 million for FY2025, 7439.24% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $595.6 million at Celestica, up from $305.9 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $595.6 million in Q4 2025, with the low at $7.9 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $333.1 million, with a median of $342.1 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents crashed 97.87% in 2024, then surged 7439.24% in 2025.
  • Over 5 years, Cash & Equivalents stood at $394.0 million in 2021, then decreased by 4.95% to $374.5 million in 2022, then fell by 1.09% to $370.4 million in 2023, then crashed by 97.87% to $7.9 million in 2024, then soared by 7439.24% to $595.6 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $595.6 million, $305.9 million, and $313.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.